HIGHLIGHTS
- who: Daniel Heudobler from the Universitu00e9 catholique de LouvainDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany, Department of Biology, University of Rome Tor Vergata, Rome, Italy have published the research: Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity, in the Journal: (JOURNAL)
- what: Conflict of interest By describing the pathophysiologic basis of the novel therapy technique, tumor tissue editing, and related outcome parameters that are supplementing those of u2018pulsed` therapies, the Research Topic detailed a new avenue to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.